263 related articles for article (PubMed ID: 18547278)
1. Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients.
Frimpong-Boateng A; Bunse A; Rüfer F; Roider J
Acta Ophthalmol; 2009 Mar; 87(2):183-7. PubMed ID: 18547278
[TBL] [Abstract][Full Text] [Related]
2. [ITAP - 6-month results of a prospective, randomised phase 3 study for evaluation of the combination therapy of PDT and intravitreal triamcinolone in exudative AMD].
Gamulescu MA; Schubert K; Thormann S; Attaran M; Dueck N; Wiechens B; Spital G; Stroux A; Wachtlin J
Klin Monbl Augenheilkd; 2009 Jan; 226(1):60-5. PubMed ID: 19173165
[TBL] [Abstract][Full Text] [Related]
3. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
[TBL] [Abstract][Full Text] [Related]
4. Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.
Hatta Y; Ishikawa K; Nishihara H; Ozawa S; Ito Y; Terasaki H
Retina; 2010 Mar; 30(3):495-502. PubMed ID: 19996828
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy combined with posterior subtenon triamcinolone acetonide injection in the treatment of choroidal neovascularization.
Lee YA; Ho TC; Chen MS; Yang CH; Yang CM
Eye (Lond); 2009 Mar; 23(3):645-51. PubMed ID: 18292791
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
[TBL] [Abstract][Full Text] [Related]
7. Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration.
Jonas JB; Spandau UH; Kamppeter BA; Harder B
Eye (Lond); 2007 Mar; 21(3):387-94. PubMed ID: 16410809
[TBL] [Abstract][Full Text] [Related]
8. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
[TBL] [Abstract][Full Text] [Related]
9. [Combined photodynamic therapy and intravitreal injection of triamcinolone acetonide in patients with wet form of AMD. Introductory report].
Mozolewska-Piotrowska K; Krzystolik K; Karczewicz D; Drobek-Słowik M; Kubasik-Kładna K
Klin Oczna; 2011; 113(7-9):233-6. PubMed ID: 22256564
[TBL] [Abstract][Full Text] [Related]
10. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
Chaudhary V; Mao A; Hooper PL; Sheidow TG
Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
[TBL] [Abstract][Full Text] [Related]
11. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.
Lee J; Freeman WR; Azen SP; Chung EJ; Koh HJ
Retina; 2007; 27(9):1205-13. PubMed ID: 18046226
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone acetonide preceding photodynamic therapy for exudative age-related macular degeneration.
Roth DB; Kulkarni KM; Walsman S; Modi A
Ophthalmic Surg Lasers Imaging; 2009; 40(5):467-71. PubMed ID: 19772270
[TBL] [Abstract][Full Text] [Related]
13. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.
Chan WM; Lai TY; Wong AL; Liu DT; Lam DS
Br J Ophthalmol; 2007 Feb; 91(2):174-9. PubMed ID: 16987898
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
Ergun E; Maár N; Ansari-Shahrezaei S; Wimpissinger B; Krepler K; Wedrich A; Stur M
Am J Ophthalmol; 2006 Jul; 142(1):10-16. PubMed ID: 16815246
[TBL] [Abstract][Full Text] [Related]
16. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.
Chan WM; Lai TY; Wong AL; Tong JP; Liu DT; Lam DS
Br J Ophthalmol; 2006 Mar; 90(3):337-41. PubMed ID: 16488958
[TBL] [Abstract][Full Text] [Related]
17. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
Augustin AJ; Schmidt-Erfurth U
Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
[TBL] [Abstract][Full Text] [Related]
18. Secondary elevated IOP and cataracts after high-dose intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization.
Ruiz-Moreno JM; Montero JA; Amat P; Lugo FL
J Glaucoma; 2009 Jan; 18(1):69-72. PubMed ID: 19142138
[TBL] [Abstract][Full Text] [Related]
19. Combined intravitreal pharmacosurgery in patients with occult choroidal neovascularization secondary to wet age-related macular degeneration.
Koss MJ; Scholtz S; Haeussler-Sinangin Y; Singh P; Koch FH
Ophthalmologica; 2010; 224(2):72-8. PubMed ID: 19707030
[TBL] [Abstract][Full Text] [Related]
20. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.
Lalwani GA; Rosenfeld PJ; Fung AE; Dubovy SR; Michels S; Feuer W; Davis JL; Flynn HW; Esquiabro M
Am J Ophthalmol; 2009 Jul; 148(1):43-58.e1. PubMed ID: 19376495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
